Start Date
December 31, 2002
Primary Completion Date
March 31, 2005
Study Completion Date
March 31, 2005
Atazanavir (immediate switch)
Capsules, Oral, 400mg, Once daily, 48 weeks.
Atazanavir (Week 24 switch)
Capsules, Oral, 400mg, Once daily, 48 weeks.
Local Institution, Phoenix
Local Institution, West Hollywood
Local Institution, Washington D.C.
Local Institution, Altamonte Springs
Local Institution, Fort Lauderdale
Local Institution, Miami
Local Institution, Tampa
Local Institution, Boston
Local Institution, Minneapolis
Local Institution, St Louis
Local Institution, East Orange
Local Institution, New York
Local Institution, Huntersville
Local Institution, Cleveland
Local Institution, Oklahoma City
Local Institution, Philadelphia
Local Institution, Columbia
Local Institution, Fort Worth
Local Institution, Houston
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY